Clinical Trial

Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

Study acronym: NB-UVB
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 29, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
20 patients will be enrolled. All were given narrowband UVB . 10 wil be give oral azathriopfine . 10 will be given tofacitinib
Trial Details
NCT Number NCT07044141
Lead Sponsor Lahore General Hospital
Conditions Vitiligo
Enrollment 20 participants
Start Date 2025-03-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-29